The biotech market in the United States is experiencing a substantial surge in demand for Tirzepatide APIs. This powerful medication, used to treat type 2 diabetes, has attracted remarkable attention from both individuals and healthcare professionals. As a result, numerous manufacturers have emerged as producers of Tirzepatide APIs in the USA. W